Healthcare IT Today September 26, 2024
Sonio, the MedTech company specializing in women’s and children’s health, today announces the official approval by the French Ministry of the Economy and Finance of the acquisition of 100% of shares by Samsung.
The deal closes following the company’s second wave of FDA clearance in 2024 and with Sonio reporting and workflow solutions operating in multiple sites across the US.
“Alongside Samsung Medison, we are excited to make significant strides in the maternal care industry. In addition, Sonio plans to continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare” says Cécile Brosset, Co-Founder and CEO at Sonio.
Established in 2020 to enhance women’s and children’s health globally through medical advancements, and supported by...
Today's Sponsors
Today's Sponsor